Literature DB >> 18314965

Subunit architecture of intact protein complexes from mass spectrometry and homology modeling.

Thomas Taverner1, Helena Hernández, Michal Sharon, Brandon T Ruotolo, Dijana Matak-Vinković, Damien Devos, Robert B Russell, Carol V Robinson.   

Abstract

Proteomic studies have yielded detailed lists of protein components. Relatively little is known, however, of interactions between proteins or of their spatial arrangement. To bridge this gap, we are developing a mass spectrometry approach based on intact protein complexes. By studying intact complexes, we show that we are able to not only determine the stoichiometry of all subunits present but also deduce interaction maps and topological arrangements of subunits. To construct an interaction network, we use tandem mass spectrometry to define peripheral subunits and partial denaturation in solution to generate series of subcomplexes. These subcomplexes are subsequently assigned using tandem mass spectrometry. To facilitate this assignment process, we have developed an iterative search algorithm (SUMMIT) to both assign protein subcomplexes and generate protein interaction networks. This software package not only allows us to construct the subunit architecture of protein assemblies but also allows us to explore the limitations and potential of our approach. Using series of hypothetical complexes, generated at random from protein assemblies containing between six and fourteen subunits, we highlight the significance of tandem mass spectrometry for defining subunits present. We also demonstrate the importance of pairwise interactions and the optimal numbers of subcomplexes required to assign networks with up to fourteen subunits. To illustrate application of our approach, we describe the overall architecture of two endogenous protein assemblies isolated from yeast at natural expression levels, the 19S proteasome lid and the RNA exosome. In constructing our models, we did not consider previous electron microscopy images but rather deduced the subunit architecture from series of subcomplexes and our network algorithm. The results show that the proteasome lid complex consists of a bicluster with two tetrameric lobes. The exosome lid, by contrast, is a six-membered ring with three additional bridging subunits that confer stability to the ring and with a large subunit located at the base. Significantly, by combining data from MS and homology modeling, we were able to construct an atomic model of the yeast exosome. In summary, the architectural and atomic models of both protein complexes described here have been produced in advance of high-resolution structural data and as such provide an initial model for testing hypotheses and planning future experiments. In the case of the yeast exosome, the atomic model is validated by comparison with the atomic structure from X-ray diffraction of crystals of the reconstituted human exosome, which is homologous to that of the yeast. Overall therefore this mass spectrometry and homology modeling approach has given significant insight into the structure of two previously intractable protein complexes and as such has broad application in structural biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314965     DOI: 10.1021/ar700218q

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  55 in total

1.  Ion mobility mass spectrometry coupled with rapid protein threading predictor structure prediction and collision-induced dissociation for probing chemokine conformation and stability.

Authors:  Milady R Niñonuevo; Julie A Leary
Journal:  Anal Chem       Date:  2012-03-16       Impact factor: 6.986

2.  Ion mobility-mass spectrometry reveals conformational changes in charge reduced multiprotein complexes.

Authors:  Russell E Bornschein; Suk-Joon Hyung; Brandon T Ruotolo
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-16       Impact factor: 3.109

3.  Elucidating the higher-order structure of biopolymers by structural probing and mass spectrometry: MS3D.

Authors:  Daniele Fabris; Eizadora T Yu
Journal:  J Mass Spectrom       Date:  2010-08       Impact factor: 1.982

4.  Norwalk virus assembly and stability monitored by mass spectrometry.

Authors:  Glen K Shoemaker; Esther van Duijn; Sue E Crawford; Charlotte Uetrecht; Marian Baclayon; Wouter H Roos; Gijs J L Wuite; Mary K Estes; B V Venkataram Prasad; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2010-04-22       Impact factor: 5.911

5.  How far can we go with structural mass spectrometry of protein complexes?

Authors:  Michal Sharon
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-04       Impact factor: 3.109

6.  Current limitations in native mass spectrometry based structural biology.

Authors:  Esther van Duijn
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-04       Impact factor: 3.109

7.  Integrative structure modeling of macromolecular assemblies from proteomics data.

Authors:  Keren Lasker; Jeremy L Phillips; Daniel Russel; Javier Velázquez-Muriel; Dina Schneidman-Duhovny; Elina Tjioe; Ben Webb; Avner Schlessinger; Andrej Sali
Journal:  Mol Cell Proteomics       Date:  2010-05-27       Impact factor: 5.911

8.  Protein Structural Studies by Traveling Wave Ion Mobility Spectrometry: A Critical Look at Electrospray Sources and Calibration Issues.

Authors:  Yu Sun; Siavash Vahidi; Modupeola A Sowole; Lars Konermann
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-14       Impact factor: 3.109

9.  Ion Mobility-Mass Spectrometry Reveals Highly-Compact Intermediates in the Collision Induced Dissociation of Charge-Reduced Protein Complexes.

Authors:  Russell E Bornschein; Shuai Niu; Joseph Eschweiler; Brandon T Ruotolo
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-01       Impact factor: 3.109

10.  Noncovalent protein tetramers and pentamers with "n" charges yield monomers with n/4 and n/5 charges.

Authors:  Richard L Beardsley; Christopher M Jones; Asiri S Galhena; Vicki H Wysocki
Journal:  Anal Chem       Date:  2009-02-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.